$11.71
Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
Overview
52-week range
$8.67
$36
11% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+1.2%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-5.37 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-5.89 | — | — | -2,577% | +1.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.23 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $-0.33 | — | — | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.22 | — | — | — | +1.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.35 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.31 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.31 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.45 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.58 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.57 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-4M | — | $-5M | $-7M | $-5M | — | $-6M |
| Net income | $-4M | $-4M | — | $-5M | $-7M | $-5M | — | $-6M |
| EPS (diluted) | $-5.37 | $-5.89 | — | $-0.23 | $-11.52 | $-7.75 | — | $-0.35 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $18M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $22M | $25M | $29M | $31M | $36M | $39M | $44M | $49M |
| Total assets | $23M | $26M | $30M | $32M | $37M | $41M | $45M | $50M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $2M | $2M | $3M | $4M | $2M | $3M | $3M |
| Total equity | $21M | $24M | $27M | $29M | $33M | $38M | $42M | $47M |
Implied volatility — last 90 days
No IV snapshots yet for NVNO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.